For a broader view of related compounds, the GLP-3 peptide and amylin receptor agonist guides cover emerging targets in the metabolic peptide space that may eventually offer weight loss with fewer side effects
It is not prescribing guidance, a recommendation, or encouragement to use, obtain, or supply any medicine
However, if you have significant facial concerns and your weight loss is nearly complete, treatment may be appropriate
Additionally, it can help control blood sugar and insulin levels, which can contribute to weight management, particularly in individuals with type 2 diabetes
HEK-Blue GLP-1 cells strongly respond to the incretin GLP-1 (7-36) amide, but not to other G protein-coupled receptor (GPCR)-activating peptide hormones, such as GIP (glucose-dependent insulinotropic polypeptide) or glucagon
Dunn L, Allen GF, Mamais A, Ling H, Li A, Duberley KE, et al